Tech Company Financing Transactions
Cascader Funding Round
On 9/23/2026, Cascader announced Seed funding from Topcon Healthcare and private investors.
Transaction Overview
Company Name
Announced On
9/23/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Topcon Healthcare (Lead Investor)
Proceeds Purpose
Cascader will use the capital to transition its artificial intelligence technologies into clinical use.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Undisclosed
London, Undisclosed
UK
London, Undisclosed
UK
Phone
Undisclosed
Website
Email Address
Overview
At Cascader, we harness the power of artificial intelligence to help clinicians -- in hospitals and in primary care -- optimise workflows and deliver better patient care. Our mission is to use AI to enable safe, evidence-based decisions in high-volume, high-risk eye conditions, preventing avoidable sight loss. We also harness oculomics for non-invasive, early detection of systemic diseases -- driving a shift toward preventative healthcare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Thomas
Chief Medical Officer
Pearse Keane
Chief Operating Officer
Ege Ilicak
Browse more venture capital transactions:
Prev: 9/23/2026: Armata Pharmaceuticals venture capital transaction
Next: 9/23/2026: Tekever venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs